Advaxis Statistics, Revenue Totals, Facts & News (2022)
Last Updated on: February 27th, 2022
Here are a few of the most interesting Advaxis statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Advaxis Facts
- Advaxis Website: Official Website
- Year Advaxis was Founded: 2002
- Advaxis Headquarters: Princeton, NJ
- Current Advaxis Chief Executive: David Sidransky
What is Advaxis?
Advaxis (NASDAQ: ADXS) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. The Advaxis technology, using bioengineered live attenuated bacteria, Listeria monocytogenes (Lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack. (source)
Advaxis Revenue Totals
Advaxis annual revenue:
- FY 2019: $20.884 million
- FY 2018: $6.063 million
Advaxis annual net income:
- FY 2019: $16.612 million
- FY 2018: $66.465 million
Recent Advaxis News
Related posts:
Please note that some of these numbers are easier to find than others. A few of these Advaxis statistics come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.
Related Categories:
Related Tags: